From: Network meta-analysis of invasive treatment for early-stage osteonecrosis of the femoral head
Author | Year | Region | Population | Age (mean, SD) | Gender (♀, ♂) | Ficat grade | ARCO stage | HHS (mean, SD) | Comparisons |
---|---|---|---|---|---|---|---|---|---|
Cao | 2017 | China | 21 | 31, 6 | 5, 16 | NA | I, 5/II, 26/III, 11 | 60, 8.03 | CD versus BG |
Aggarwal | 2020 | India | 40 | NA | 3, 37 | I, 13/II, 40 | I, 13/II, 40 | 63.49, 8.04 | CD versus CD + PRP |
Li | 2016 | China | 39 | 36.5 | 12, 27 | I, 21/II, 26 | NA | 63.71, 3.58 | BG versus CD + BG |
Gangji | 2011 | Belgium | 19 | 45.7, 2.8 | 10, 9 | NA | I, 4/II, 20 | NA | CD versus CD + BMMSC |
Fu | 2022 | China | 40 | 38.98, 3.95 | 11, 29 | NA | I, 27/II, 13 | 77.73, 2.67 | CD versus CD + BMMSC |
Ma | 2014 | China | 43 | 35.22, 9.66 | 11, 28 | I, 7/II, 32/III, 10 | NA | NA | CD + BG versus CD + BG + BMMSC |
Hauzeur | 2018 | Belgium | 38 | 48.85, 3.09 | 11, 27 | NA | III, 46 | NA | CD versus CD + BMMSC |
Rastogi | 2013 | India | 40 | 33.84, 7.36 | 11, 29 | NA | I, 14/II, 22/III, 24 | 46.92, 1.70 | CD + BG versus CD + BMMSC |
Zhao | 2012 | China | 100 | 33.25, 9.18 | 47, 53 | NA | I, 5/II, 99 | 42.75, 4.50 | CD versus CD + BMMSC |
Tabatabaee | 2015 | Iran | 28 | 28.9, 9.13 | 9, 19 | NA | I, 5/II, 16/III, 7 | NA | CD versus CD + BMMSC |
Sen | 2012 | India | 40 | NA | 13, 27 | NA | I, II, 51 | 65.96, 14.02 | CD versus CD + BMMSC |
Chang | 2010 | China | 8 | 35.7 | 1, 7 | NA | II, 14/III, 2 | 56.19, 8.60 | CD versus CD + BMMSC |
Chen | 2016 | China | 71 | 38.39, 10.11 | 27, 44 | I, II, 51/III, 20 | NA | 39.63, 5.9 | CD versus CD + SAI |
Wang | 2017 | China | 30 | NA | 11, 19 | NA | I, 17/II, 22 | NA | CD versus CD + BG |
Yu | 2014 | China | 48 | 37.77, 8.39 | 33, 15 | NA | I, 9/II, 41/III, 23 | 52.96, 6.88 | CD versus CD + BMMSC |